Biogen Inc (BIIB)
293.50
-19.60 -6.26%
NASDAQ
Dec 18, 16:58
Delayed 2m
USD
View All Key Stats
BIIB Key Stats
| Income Statement | |
| Revenue (TTM) | 13.23B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 15.49 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 3.186B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 86.60% |
| Profit Margin (Quarterly) | 42.00% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 59.14B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.619 |
| PE Ratio (TTM) | 18.95 |
| Price to Book Value | 4.296 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 1.545B |
| Return on Equity (TTM) | Upgrade |
View All BIIB News
BIIB News
-
WireHeadlineTime (ET)
-
MT Newswires12/18 16:19
-
MT Newswires12/18 16:00
-
Yahoo12/18 14:27
-
Yahoo12/18 13:21
-
Yahoo12/18 13:21
-
Yahoo12/18 13:21
-
MT Newswires12/18 12:37
-
MT Newswires12/18 12:22
-
Yahoo12/18 11:55
-
SA Breaking News12/18 11:53
View All Events
BIIB Events
| Date | Type | Description |
|---|---|---|
| 01/25/2019 08:30 EST | Misc | Biogen Inc Fourth Quarter Earnings Conference Call in 2018 |
| 01/25/2019 | Earnings | Biogen Inc Fourth Quarter Earnings in 2018 Release |
| 10/23/2018 08:00 EDT | Misc | Biogen Inc Third Quarter Earnings Conference Call in 2018 |
| 10/23/2018 | Earnings | Biogen Inc Third Quarter Earnings Results in 2018 |
| 07/24/2018 08:00 EDT | Misc | Biogen Inc Second Quarter Earnings Conference Call in 2018 |
| 07/24/2018 | Earnings | Biogen Inc Second Quarter Earnings Results in 2018 |
| 06/12/2018 | Misc | Biogen Inc Annual General Meeting in 2017 |
| 04/24/2018 08:30 EDT | Misc | Biogen Inc First Quarter Earnings Conference Call in 2018 |
| 04/24/2018 | Earnings | Biogen Inc First Quarter Earnings Results in 2018 |
| 02/01/2018 | Misc | Biogen Inc Annual Report in 2017 |
BIIB Fundamentals
Income Statement View Statement
BIIB Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BIIB One Page Reports
- One Page Report Download
BIIB Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 293.50 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.biogen.com
- Investor Relations URL: https://www.biogen.com/en_us/investors.html
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Blend
- Next Earnings Release: Jan. 25, 2019
- Last Earnings Release: Oct. 23, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
BIIB Excel Add-In Codes
- Name: =YCI("BIIB","name")
- Description: =YCI("BIIB","description")
- Sector: =YCI("BIIB","sector")
- Industry: =YCI("BIIB","industry")
- Est. Current Fiscal Year End: =YCI("BIIB","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BIIB Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BIIB Tweets Stocktwits
Advertisement
